GPR40 Carboxylic Acid Receptor Family and Diabetes: A New Drug Target

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|9|10|899-910

ISSN： 1389-4501

Source： Current Drug Targets, Vol.9, Iss.10, 2008-10, pp. : 899-910

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Advances in Development of GPR40 Modulators (FFA1/FFAR1): An Emerging Target for Type 2 Diabetes

By  

Mini Reviews in Medicinal Chemistry, Vol. 17, Iss. 11, 2017-06 ,pp. : 947-958

Bentham Science Publishers

Access to resources Recommend Favorite

(Pro)renin Receptor as a New Drug Target

By  

Current Pharmaceutical Design, Vol. 17, Iss. 33, 2011-11 ,pp. : 3611-3621

Bentham Science Publishers

Access to resources Recommend Favorite

GPR40 Agonists for the Treatment of Type 2 Diabetes Mellitus: Benefits and Challenges

By  

Current Drug Targets, Vol. 17, Iss. 11, 2016-07 ,pp. : 1292-1300

Bentham Science Publishers

Access to resources Recommend Favorite

The NMDA/D1 Receptor Complex as a New Target in Drug Development

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 8, 2006-04 ,pp. : 801-808

Bentham Science Publishers

Access to resources Recommend Favorite

Novel selective ligands for free fatty acid receptors GPR120 and GPR40

By Hara Takafumi  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 380, Iss. 3, 2009-09 ,pp. : 247-255

Springer Publishing Company

Access to resources Recommend Favorite